Medtronic of Canada on Life Science Investing News

 Medtronic of Canada Ltd. (NYSE:MDT) is a health systems solution provider in advanced medical technologies that help alleviate pain, restore health and extend life in the areas of Cardiac Rhythm Disease Management, Spinal and Biologics, Surgical Navigation, Cardiovascular, Neuromodulation, ENT and Neurologics, and Diabetes. The first company to perfect and market the reliable, long-term implantable pacemaker, Medtronic is leading the way once again with the development of an artificial pancreas to help diabetes patients manage their insulin levels and extend their life.

Click here to read more about Medtronic of Canada (NYSE:MDT) on Life Science Investing News